series-c-plus
Stage
3
Investors
About
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying its ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines.
Explore NuCana's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.